![]() |
Volumn 30, Issue 10, 2012, Pages 923-926
|
Innovative drugs and vaccines in China, India and Brazil
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
CANCER VACCINE;
HEPATITIS E VACCINE;
INFLUENZA VACCINE;
INSULIN;
MALARIA VACCINE;
MONOCLONAL ANTIBODY;
NEW DRUG;
PEPTIDE;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;
PLANT EXTRACT;
RECOMBINANT PROTEIN;
VACCINE;
VANILLOID RECEPTOR 3;
VANILLOID RECEPTOR ANTAGONIST;
BIOTECHNOLOGY;
BRAZIL;
BREAST CANCER;
CARDIOVASCULAR DISEASE;
CHINA;
COLON CANCER;
DIABETES MELLITUS;
DRUG APPROVAL;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
GENE PRODUCT;
GENE THERAPY;
HEART FAILURE;
HEPATITIS E;
HUMAN;
INDIA;
INFECTION;
INFLUENZA A (H1N1);
LETTER;
LUNG CANCER;
MALARIA;
MEDICINAL PLANT;
MYELOMA;
OVARY CANCER;
PAIN;
PATENT;
PRIORITY JOURNAL;
PROSTATE CANCER;
PSORIASIS;
RHEUMATOID ARTHRITIS;
SKIN DISEASE;
STEM CELL TRANSPLANTATION;
BIOTECHNOLOGY;
BRAZIL;
CHINA;
DATA COLLECTION;
DRUG APPROVAL;
DRUG DISCOVERY;
HUMANS;
INDIA;
LICENSURE, PHARMACY;
PHARMACEUTICAL PREPARATIONS;
THERAPIES, INVESTIGATIONAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VACCINES;
|
EID: 84867380623
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.2380 Document Type: Letter |
Times cited : (23)
|
References (12)
|